Printer-friendly versionPrinter-friendly version

Burden and Prevention of Viral Hepatitis in Arctic Region

Copenhagen, Denmark, March 22-23, 2012

Thursday, March 22, 2012

Session 1  Opening and objectives
Chair:  Brian McMahon and Pierre Van Damme

09.00 - 09.30

  • Welcome and opening
  • Introduction of the participants
  • Introduction of the VHPB
  • Objectives of the meeting:
    • Provide an overview of surveillance systems for infectious diseases;
    • Review the epidemiological situation on viral hepatitis and explain the higher prevalence of viral hepatitis;
    • Give an overview of the current prevention and control measures on viral hepatitis;
    • Discuss the progress achieved in hepatitis prevention;
    • Review the possible implementation of new prevention strategies, control measures and monitoring systems;
    • Discuss the successes, issues and barriers to overcome, and the way forward;
    • The aim of the meeting is to focus on the indigenous ethnic population of this region
  • Review of the meeting programme
  • Pre-meeting document  787 Kb (.pdf)

09.15 – 09.40  
General introduction: Circumpolar Health: improving the health of the indigenous population and role of Circumpolar Health Organizations.   6.7 Mb (.pdf)
Alan Parkinson (CDC, International Circumpolar Surveillance Steering Committee)

Session 2 THE HEALTH CARE SYSTEMS, COMMUNICABLE DISEASE CONTROL AND VIRAL HEPATITIS SURVEILLANCE SYSTEMS IN THE ARCTIC REGION
Chair:  John Ward and Anders Koch

09.40– 09.55 
Alaska: The health care systems and communicable disease control  2.9 Mb (.pdf)
Brian McMahon

09.55 – 10.10 
Alaska: Hepatitis Surveillance system in Alaska, including hepatitis A  405 Kb (.pdf)
Timothy Thomas

10.10 – 10.30 
Canada: The health care systems and communicable disease control and hepatitis Surveillance in Canada   2.5 Mb (.pdf)
Bryce Larke

10.30 – 10.45 
Greenland: The health care systems, communicable diseases control and introduction of vaccination against Hepatitis B in childhood immunization program   1.6Mb (.pdf)
Flemming Kleist Stenz

10.45 – 11.05 Discussion

11.05 – 11.20 Coffee break

Chair:  Erika Duffel and Hande Harmanci 

11.20– 11.35
Greenland: Hepatitis Surveillance system and a population -based registry study of infant mortality in Arctic.  908 Kb (.pdf)
Anders Koch

11.35– 11.50
Greenland: DANHEP: clinical hepatitis database in Denmark and Greenland. 1 Mb (.pdf)
Nina Weis 

11.50– 12.10
Iceland: The health care systems and communicable disease control and hepatitis Surveillance.  586 Kb (.pdf)
Thorolfur Gudnason

12.10– 12.20
Nordic Countries: The health care systems and communicable disease control.  523 Kb (.pdf)
Hans Blystad

12.20 – 12.45 Discussion

12.45 – 14.00 Lunch

Session 3 EPIDEMIOLOGY OF VIRAL HEPATITIS IN THE ARCTIC REGION
Chair: Helène Norder and Alessandro Zanetti

14.00 – 14.15
Norway: Hepatitis surveillance system and epidemiology in Northern Norway.   198 Kb (.pdf)
Hans Blystad

14.15 – 14.30
Sweden: Hepatitis surveillance system and epidemiology in Northern Sweden.   2 Mb (.pdf)
Anders Nystedt

14.30 – 14.45
Finland: Hepatitis surveillance system and epidemiology in Northern Finland.    915 Kb (.pdf)
Markky Kuusi 

14.45 – 15.05
Alaska: Epidemiology of Viral hepatitis in Alaska. 776 Kb (.pdf)
Brian McMahon  

15.05 – 15.25
Greenland: Population-based comparative epidemiological survey of hepatitis B, D, and C among Inuit migrated to Denmark and in high endemic Greenland.    94 Kb (.pdf)
Henrik Krarup  

15.25 – 15.45
Greenland: Molecular epidemiology: Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in Arctic indigenous populations.   885 Kb (.pdf)
Anders Koch 

15.45 – 16.05 Discussion

16.05 – 16.20 Coffee break

Chair:  Angela Dominguez and Daniel Shouval

16.20 – 16.40
Greenland: Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland    1.2 Mb (.pdf)
Malene Landbo Børresen

16.40 – 17.00
Iceland: Epidemiology of viral hepatitis in Iceland.   1.6  Mb (.pdf)
Thorolfur Gudnason

17.00 – 17.20
Russia: Epidemiology of viral hepatitis in Russia (Arctic region).   5.4  Mb (.pdf)
Andrey Tulisov

17.20 – 17.40
Canada: The Epidemiology and Natural History of Viral Hepatitis in the Canadian North.  1 Mb (.pdf)
Gerald Minuk

17.40 – 18.00   Discussion

18.00                 End of the Day

Friday, March 23, 2012

Session 4  PREVENTION AND CONTROL OF VIRAL HEPATITIS LESSONS LEARNT AND THE WAY FORWARD
Chair: Francoise Roudot-Thoraval and Daniel Lavanchy

09.00 – 09.20
Alaska: Long-term hepatitis B immunogenicity studies in Alaska and the impact of vaccination on cirrhosis, chronic hepatitis B and liver cancer.   3.6  Mb (.pdf)
Lisa Bulkow

09.20 – 09.40
Alaska: Statewide Hepatitis A vaccination program over the last 25 years.   242 Kb (pdf)
Timothy Thomas

09.40 – 10.00
Canada: Hepatitis Prevention and control in Canada   1.2 Mb (.pdf)
Bryce Larke

10.00 – 10.20
Greenland: Effectiveness of the Targeted Hepatitis B Vaccination Program in Greenland      2.4 Mb (.pdf)
Malene Landbo Børresen

10.20 – 10.40 Coffee break

Chair: Rui Tato Marinho and Mira Kojouharova

10.40 – 11.00
Iceland: An interactive central database of vaccinations in Iceland and hepatitis B prevention programme.   1.5 Mb (.pdf)
Thorolfur Gudnason

11.00 – 11.20
Russia: Hepatitis prevention activities in Northern Russia (Arkhangelsk region).     249 Kb (.pdf)
Andrey Tulisov 

11.20 – 11.40
Sweden: Hepatitis C incidence and prevention activities targeting young people in Norrbotten County, Sweden.     134 Kb (.pdf)
Ann-Louise Svedberg Lindqvist

11.40 – 12.00   Discussion

12.00 – 12.20
Greenland: Implementation and effectiveness of hepatitis B strategy in Greenland   1.1  Mb (.pdf)
Karin Ladeföged

12.20 – 12.40
Alaska: Management of Chronic Hepatitis B and C in Alaska Natives including surveillance for hepatocellular carcinoma  646 Kb (.pdf)
Brian McMahon

12.40 – 13.00 Discussion

13.00 – 14.30 Lunch

Session 5 Conclusions of the meeting
Chair: Johannes Hallauer and Hans Blystad

14.30 – 15.30
Presentation of the VHPB meeting conclusions    51 Kb(.pdf)
David FitzSimons

15.30 Close of the meeting

Tags: